Young Suk Lim (Young S Lim, Young-Suk Lim, Y-S Lim)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 64

Top Venues

Alimentary pharmacology & therapeutics

Journal of liver cancer

Journal of viral hepatitis

Liver international : official journal of the International Association for the Study of the Liver

University of Ulsan College of Medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Ulsan College of Medicine Mar 1o 2003

South Korea

Professor

Publications

Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Scott K Fung, Calvin Qian Pan, Grace Lai-Hung Wong, Wai Kay Seto, Sang Hoon Ahn, Chi-Yi Chen, Hie-Won L Hann, Maciej S Jablkowski, Yun Joon Kim, Cihan Yurdaydin, Cheng-Yuan Peng, Tuan Nguyen, Hiroshi Yatsuhashi, John F Flaherty, Leland J Yee, Frida Abramov, Hongyuan Wang, Dzhamal Abdurakhmanov, Young Suk Lim, Maria Buti Ferret
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks. Alimentary pharmacology & therapeutics (2023)
Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Su Jin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment. Journal of liver cancer 23 (1) (2023)
Su Jin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment. Journal of liver cancer 23 (1) (2023)
Su Jin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment. Journal of liver cancer 23 (1) (2023)
Won-Mook Choi, Young Suk Lim
Editorial: Time to consider early treatment for chronic hepatitis B in both children and adults. Alimentary pharmacology & therapeutics 58 (9) (2023)
Won-Mook Choi, Seo Yeon Yoo, Jong-In Chang, Seungbong Han, Young Seok Kim, Dong Hyun Sinn, Sang Hyun Choi, Dong Il Gwon, Young Suk Lim
A model for predicting poor survival in patients with cirrhosis undergoing portosystemic shunt embolization. Journal of gastroenterology and hepatology (2023)
Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Su Jin Jin, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jinhong Jung, Sang Min Yoon, Jonggi Choi
Subclassification of advanced-stage hepatocellular carcinoma with macrovascular invasion: combined transarterial chemoembolization and radiotherapy as an alternative first-line treatment. Journal of liver cancer 23 (1) (2023)
Young Suk Lim, W Ray Kim, Douglas Dieterich, Jia-Horng Kao, John F Flaherty, Leland J Yee, Lewis Rowland Roberts, Homie Razavi, Patrick T F Kennedy
Evidence for Benefits of Early Treatment Initiation for Chronic Hepatitis B. Viruses 15 (4) (2023)
Won-Mook Choi, Gi-Ae Kim, Jonggi Choi, Gwang Hyeon Choi, Yun Bin Lee, Dong Hyun Sinn, Young Suk Lim
Non-linear association of baseline viral load with on-treatment hepatocellular carcinoma risk in chronic hepatitis B. Gut (2023)
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jin-Hong Park, Sang Min Yoon
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study. Journal of liver cancer 22 (2) (2022)
Man Fung Yuen, Elina Berliba, Wattana Sukeepaisarnjaroen, Sang Hoon Ahn, Tawesak Tanwandee, Young Suk Lim, Yun Joon Kim, Kittiyod Poovorawan, Pisit Tangkijvanich, Christian Schwabe, Timothy Eley, Joanne Brown, Amy C H Lee, Emily P Thi, Bhavna Paratala, Nagraj Mani, Michael J Sofia, Gaston Picchio, Karen D Sims, Edward J Gane
Safety, pharmacokinetics, and antiviral activity of the capsid inhibitor AB-506 from Phase 1 studies in healthy subjects and those with hepatitis B. Hepatology communications 6 (12) (2022)
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jin-Hong Park, Sang Min Yoon
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study. Journal of liver cancer 22 (2) (2022)
Young Suk Lim, Sang Hoon Ahn, Jae-Jun Shim, Homie Razavi, Devin Razavi-Shearer, Dong Hyun Sinn
Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis. Alimentary pharmacology & therapeutics 56 (3) (2022)
Won-Mook Choi, Young Suk Lim
Use of hepatitis B virus DNA and liver stiffness in predicting clinical events in patients with chronic hepatitis B. Journal of viral hepatitis 29 (4) (2022)
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jin-Hong Park, Sang Min Yoon
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study. Journal of liver cancer 22 (2) (2022)
Jeong Yun Jang, Jinhong Jung, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jin-Hong Park, Sang Min Yoon
Stereotactic body radiation therapy for elderly patients with small hepatocellular carcinoma: a retrospective observational study. Journal of liver cancer 22 (2) (2022)
Jonggi Choi, Jina Park, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Young-Hwa Chung
The Korean Hepatitis C Virus Care Cascade in a Tertiary Institution: Current Status and Changes in Testing, Link to Care, and Treatment. Gut and liver 16 (6) (2022)
Byoung Je Kim, Sang Hyun Choi, So Yeon Kim, Young Suk Lim, So Jung Lee, Jae Ho Byun, Hyung Jin Won
Liver Imaging Reporting and Data System categories: Long-term imaging outcomes in a prospective surveillance cohort. Liver international : official journal of the International Association for the Study of the Liver 42 (7) (2022)
Jihye Lim, Seungbong Han, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Dong Hwan Jung, Sung-Gyu Lee, Ki-Hun Kim, Jonggi Choi
Identification of hepatic steatosis in living liver donors by machine learning models. Hepatology communications 6 (7) (2022)
Young Suk Lim, Pietro Lampertico
Editorial: does TAF have a better or worse safety profile than TDF, to treat hepatitis B? Authors' reply. Alimentary pharmacology & therapeutics 55 (8) (2022)
Man Fung Yuen, Chi-Yi Chen, Chun-Jen Liu, Wen-Juei Jeng, Magdy Elkhashab, Carla S Coffin, Won Kim, Susan Greenbloom, Alnoor Ramji, Young Suk Lim, Yoon Jun Kim, Scott K Fung, Dong Joon Kim, Jeong Won Jang, Kwan Sik Lee, Radhakrishnan P Iyer, Chelsea Macfarlane, Kathy Jackson, Stephen A Locarnini, Henry Lik Yuen Chan, Nezam H Afdhal
A phase 2, open-label, randomized, multiple-dose study evaluating Inarigivir in treatment-naïve patients with chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver (2022)
Kosh Agarwal, Jia Xu, Edward J Gane, Tuan T Nguyen, Yanhua Ding, Steven J Knox, Katia Alves, Marc Evanchik, Katie Zomorodi, Julie Ma, Ran Yan, Qi Huang, Richard Colonno, Luisa M Stamm, Tarek I Hassanein, Dong Joon Kim, Young Suk Lim, Man-Fung Yuen
Safety, pharmacokinetics, and antiviral activity of ABI-H2158, a hepatitis B virus core inhibitor: a randomized, placebo-controlled Phase 1 study. Journal of viral hepatitis (2022)
Jihye Lim, Won-Mook Choi, Ju Hyun Shim, Danbi Lee, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Jonggi Choi
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naïve chronic hepatitis B. Liver international : official journal of the International Association for the Study of the Liver 42 (7) (2022)
Won-Mook Choi, Hyo Jeong Kim, Ae Jeong Jo, So Hyun Choi, Seungbong Han, Min Jung Ko, Young Suk Lim
Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study. Liver international : official journal of the International Association for the Study of the Liver 41 (11) (2021)
Hyo Jung Park, So Yeon Kim, Amit G Singal, So Jung Lee, Hyung Jin Won, Jae Ho Byun, Sang Hyun Choi, Takeshi Yokoo, Min-Ju Kim, Young Suk Lim
Abbreviated magnetic resonance imaging vs ultrasound for surveillance of hepatocellular carcinoma in high-risk patients. Liver international : official journal of the International Association for the Study of the Liver (2021)
Gi Ae Kim, Young Suk Lim
Letter: serum hepatitis B virus DNA and risk of hepatocellular carcinoma in patients with chronic hepatitis B-authors' reply. Alimentary pharmacology & therapeutics 53 (6) (2021)
Jonggi Choi, Young Suk Lim
Secondary prevention of hepatitis B virus-related hepatocellular carcinoma with current antiviral therapies. The Kaohsiung journal of medical sciences 37 (4) (2021)
Eo-Jin Kim, Changhoon Yoo, Hyo Jeong Kang, Kyu-Pyo Kim, Min-Hee Ryu, Sook Ryun Park, Danbi Lee, Jonggi Choi, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Han Chu Lee, Baek-Yeol Ryoo
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinoma. Liver international : official journal of the International Association for the Study of the Liver 41 (6) (2021)
Won-Mook Choi, Ji Yoon Kim, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Young Suk Lim, Han Chu Lee, Changhoon Yoo, Min-Hee Ryu, Baek-Yeol Ryoo, Kang Mo Kim
Kinetics of the neutrophil-lymphocyte ratio during PD-1 inhibition as a prognostic factor in advanced hepatocellular carcinoma. Liver international : official journal of the International Association for the Study of the Liver 41 (9) (2021)
Edward Gane, Man-Fung Yuen, Dong Joon Kim, Henry Lik-Yuen Chan, Bernadette Surujbally, Vedran Pavlovic, Sudip Das, Miriam Triyatni, Remi Kazma, Joseph F Grippo, Simon Buatois, Annabelle Lemenuel-Diot, Ben-Fillippo Krippendorff, Henrik Mueller, Yuchen Zhang, Hyung Joon Kim, Apinya Leerapun, Tien Huey Lim, Young Suk Lim, Tawesak Tanwandee, Won Kim, Wendy Cheng, Tsung-Hui Hu, Cynthia Wat
Clinical Study of Single-Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B. Hepatology (Baltimore, Md.) 74 (4) (2021)
Jonggi Choi, Young Suk Lim
Reply. Hepatology (Baltimore, Md.) 73 (3) (2021)
Ji Hyeon Lee, Young Suk Lim, Jeong-Hoon Lee, Geum-Youn Gwak, Misol Do, Injoon Yeo, Dongyoon Shin, Dohyun Han, Taesung Park, Youngsoo Kim
Inclusive Quantification Assay of Serum Des-γ-Carboxyprothrombin Proteoforms for Hepatocellular Carcinoma Surveillance by Targeted Mass Spectrometry. Hepatology communications 5 (10) (2021)
Edward J Gane, Hyung Joon Kim, Kumar Visvanathan, Yoon Jun Kim, Anh-Hoa Nguyen, Jeffrey J Wallin, Diana Y Chen, Circe McDonald, Priyanka Arora, Susanna K Tan, Anuj Gaggar, Stuart K Roberts, Young Suk Lim
Safety, Pharmacokinetics, and Pharmacodynamics of the Oral TLR8 Agonist Selgantolimod in Chronic Hepatitis B. Hepatology (Baltimore, Md.) 74 (4) (2021)
Jeong Heo, Yun Joon Kim, Jin-Woo Lee, Ji Hoon Kim, Young Suk Lim, Kwang-Hyub Han, Sook-Hyang Jeong, Mong Cho, Ki Tae Yoon, Si Hyun Bae, Eric D Crown, Linda M Fredrick, Negar Niki Alami, Armen Asatryan, Do Hyun Kim, Seung-Woon Paik, Youn Jae Lee
Efficacy and Safety of Glecaprevir/Pibrentasvir in Korean Patients with Chronic Hepatitis C: A Pooled Analysis of Five Phase II/III Trials. Gut and liver 15 (6) (2021)
Young Suk Lim
Role of Tumor Biomarkers in the Surveillance of Hepatocellular Carcinoma. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi 78 (5) (2021)
Ae Jeong Jo, Won-Mook Choi, Hyo Jeong Kim, So Hyun Choi, Seung-Bong Han, Min Jung Ko, Young Suk Lim
A risk scoring system to predict clinical events in chronic hepatitis B virus infection: A nationwide cohort study. Journal of viral hepatitis (2021)
Jayoun Lee, Gi-Ae Kim, Hyo Jeong Kim, Songhee Cho, Min Jung Ko, Young Suk Lim
Tenofovir disoproxil fumarate on the risk of hepatocellular carcinoma in chronic hepatitis B patients with failure to preceding treatments: A nationwide cohort study. Journal of viral hepatitis 28 (8) (2021)
Gi Ae Kim, Young Suk Lim
Editorial: hepatitis B DNA thresholds and risk of hepatocellular carcinoma: different number patterns in HBeAg-positive versus HBeAg-negative patients. Authors' reply. Alimentary pharmacology & therapeutics 51 (12) (2020)
Jonggi Choi, Sun Yoo, Young Suk Lim
Comparison of Long-Term Clinical Outcomes Between Spontaneous and Therapy-Induced HBsAg Seroclearance. Hepatology (Baltimore, Md.) (2020)
Yu-Rang Park, HaYeong Koo, Young-Kwang Yoon, Sumi Park, Young Suk Lim, Seunghee Baek, Hae-Reong Kim, Tae Won Kim
Expedited Safety Reporting to Sponsors Through the Implementation of an Alert System for Clinical Trial Management at an Academic Medical Center: Retrospective Design Study. JMIR medical informatics 8 (2) (2020)
Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young Suk Lim, Yung Sang Lee, Han Chu Lee
Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma. PloS one 15 (3) (2020)
Jonggi Choi, Young Suk Lim
REPLY. Hepatology (Baltimore, Md.) 73 (1) (2020)
Gwang Hyeon Choi, Young Suk Lim
Letter: risk of developing hepatocellular carcinoma in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Authors' reply. Alimentary pharmacology & therapeutics 50 (5) (2020)
Jia-Horng Kao, Tsung-Hui Hu, Ji-Dong Jia, Masayuki Kurosaki, Young Suk Lim, Han-Chieh Lin, Dong Hyun Sinn, Yasuhito Tanaka, Vincent Wai-Sun Wong, Man Fung Yuen
East Asia expert opinion on treatment initiation for chronic hepatitis B. Alimentary pharmacology & therapeutics 52 (10) (2020)
Jonggi Choi, Chanyoung Jo, Young Suk Lim
Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection. Hepatology (Baltimore, Md.) 73 (2) (2020)
Minseok Albert Kim, Seung-Up Kim, Dong Hyun Sinn, Jeong Won Jang, Young Suk Lim, Sang Hoon Ahn, Jae-Jun Shim, Yeon Seok Seo, Yang Hyun Baek, Sang Gyune Kim, Young Seok Kim, Ji Hoon Kim, Won Hyeok Choe, Hyung Joon Yim, Hyun Woong Lee, Jung Hyun Kwon, Sung Won Lee, Jae Young Jang, Hwi Young Kim, Dong Hyun Sinn, Gi Ae Kim, Hyun Yang, Han Ah Lee, Myeongseok Koh, Young-Sun Lee, Minkoo Kim, Young Chang, Yun Joon Kim, Jung Hwan Yoon, Fabien Zoulim, Jeong-Hoon Lee
Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study. Gut 69 (12) (2020)
Injoon Yeo, Gi-Ae Kim, Hyunsoo Kim, Ji Hyeon Lee, Areum Sohn, Geum-Youn Gwak, Jeong-Hoon Lee, Young Suk Lim, Youngsoo Kim
Proteome Multimarker Panel With Multiple Reaction Monitoring-Mass Spectrometry for Early Detection of Hepatocellular Carcinoma. Hepatology communications 4 (5) (2020)
Jayoun Lee, Songhee Cho, Hyo Jeong Kim, Hangil Lee, Min Jung Ko, Young Suk Lim
High level of medication adherence is required to lower mortality in patients with chronic hepatitis B taking entecavir: A nationwide cohort study. Journal of viral hepatitis 28 (2) (2020)
Gi Ae Kim, Seungbong Han, Gwang Hyeon Choi, Jonggi Choi, Young Suk Lim
Moderate levels of serum hepatitis B virus DNA are associated with the highest risk of hepatocellular carcinoma in chronic hepatitis B patients. Alimentary pharmacology & therapeutics 51 (11) (2020)
Won-Mook Choi, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Young Suk Lim, Han Chu Lee, Young-Hwa Chung, Young-Sang Lee, Sook Ryun Park, Min-Hee Ryu, Baek-Yeol Ryoo, So Jung Lee, Kang Mo Kim
Regorafenib Versus Nivolumab After Sorafenib Failure: Real-World Data in Patients With Hepatocellular Carcinoma. Hepatology communications 4 (7) (2020)
Hye-Lin Kim, Gi-Ae Kim, Jae-A Park, Hye-Rim Kang, Eui-Kyung Lee, Young Suk Lim
Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B. Gut 70 (11) (2020)
Gi Ae Kim, Young Suk Lim
Letter: moderate levels of serum hepatitis B virus DNA alone are not associated with increased risk of hepatocellular carcinoma in chronic hepatitis B patients. Authors' reply. Alimentary pharmacology & therapeutics 52 (3) (2020)
Gwang Hyeon Choi, Gi-Ae Kim, Jonggi Choi, Seungbong Han, Young Suk Lim
High risk of clinical events in untreated HBeAg-negative chronic hepatitis B patients with high viral load and no significant ALT elevation. Alimentary pharmacology & therapeutics 50 (2) (2019)
Jung Hee Son, Sang Hyun Choi, So Yeon Kim, Hye Young Jang, Jae Ho Byun, Hyung Jin Won, Hyung Jin Won, Young Suk Lim
Validation of US Liver Imaging Reporting and Data System Version 2017 in Patients at High Risk for Hepatocellular Carcinoma. Radiology 292 (2) (2019)
Zobair M Younossi, Linda Henry, Janus P Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young Suk Lim, Yock Young Dan, Ming-Lung Yu, Maria Stepanova
Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia. Alimentary pharmacology & therapeutics 49 (6) (2019)
Ken Liu, Jonggi Choi, An Le, Terry Cheuk-Fung Yip, Vincent Wai-Sun Wong, Stephen Lam Chan, Henry Lik Yuen Chan, Mindie H Nguyen, Young Suk Lim, Grace Lai-Hung Wong
Tenofovir disoproxil fumarate reduces hepatocellular carcinoma, decompensation and death in chronic hepatitis B patients with cirrhosis. Alimentary pharmacology & therapeutics 50 (9) (2019)
Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V Nguyen, Ching Lung Lai, Henry Lik Yuen Chan, Lai Wei
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection. Journal of viral hepatitis 25 (12) (2018)
Jeong-Hoon Lee, Joon Hyeok Lee, Young Suk Lim, Jong Eun Yeon, Tae-Jin Song, Su Jong Yu, Geum-Youn Gwak, Kang Mo Kim, Yun Joon Kim, Jae Won Lee, Jung Hwan Yoon
Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up. Cancer immunology, immunotherapy : CII 68 (1) (2018)
Zobair M Younossi, H L Y Chan, Y Y Dan, M H Lee, Young Suk Lim, E Kruger, S C Tan
Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia. Journal of viral hepatitis 25 (3) (2017)
G-A Kim, S Han, H-D Kim, J An, Young Suk Lim
Higher risk of hepatocellular carcinoma in chronic hepatitis B vs chronic hepatitis C after achievement of virologic response. Journal of viral hepatitis 24 (11) (2017)
Jonggi Choi, Young Suk Lim
Lamivudine: fading into the mists of time. Clinical and molecular hepatology 23 (4) (2017)

Young Suk Lim.css-eqlu8i{font-size:small;padding-left:4px;} (Young S Lim, Young-Suk Lim, Y-S Lim)

Publication Activity (10 Years)

Top Topics

Top Venues

Young Suk Lim (Young S Lim, Young-Suk Lim, Y-S Lim)